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reveals tether-controlled activity for the
phosphatase SHP-1
Jesse Goyette,1* Citlali Solis Salas,2 Nicola Coker-Gordon,1 Marcus Bridge,1 Samuel A. Isaacson,3
Jun Allard,4 Omer Dushek1,2†Tethered enzymatic reactions are ubiquitous in signaling networks but are poorly understood. A previously un-
reportedmathematical analysis is established for tethered signaling reactions in surface plasmon resonance (SPR).
Applying the method to the phosphatase SHP-1 interacting with a phosphorylated tether corresponding to an
immune receptor cytoplasmic tail provides five biophysical/biochemical constants from a single SPR experiment:
two binding rates, two catalytic rates, and a reach parameter. Tether binding increases the activity of SHP-1 by
900-fold through a binding-induced allosteric activation (20-fold) and amore significant increase in local substrate
concentration (45-fold). The reach parameter indicates that this local substrate concentration is exquisitely sen-
sitive to receptor clustering. We further show that truncation of the tether leads not only to a lower reach but also
to lower binding and catalysis. This work establishes a new framework for studying tethered signaling processes
and highlights the tether as a control parameter in clustered receptor signaling.INTRODUCTION
A common theme in signal transduction pathways is the tethering of
signaling enzymes near their substrates before catalysis (1, 2). Familiar
examples include reactions on surface receptors, where cytoplasmic
enzymes first bind to receptor tails (tethers) before catalyzing reac-
tions on substrates within reach. Understanding of these complicated
reactions is limited because they depend not only on the catalytic rate
but also on the tether reach and on the binding kinetics that localize
the enzyme. Moreover, many cell surface receptors cluster, but how
clustering influences reaction rates is poorly understood (3).
A large group of immune surface receptors rely on the tethering of
cytoplasmic kinases and phosphatases to both initiate and integrate
signaling (4). Their unstructured cytoplasmic tails containmultiple tyro-
sines that serve as both docking sites and substrates for these enzymes. In
the case of inhibitory immune receptors (for example, PD-1 andLAIR-1),
tyrosines in conserved immunotyrosine-based inhibitory or switchmotifs
(ITIMs or ITSMs) generate docking sites for the SH2 domains of the cy-
tosolic phosphatases SHP-1 and/or SHP-2.When tethered, these phos-
phatases are thought to undergo allosteric catalytic activation (5–8) to
dephosphorylate various membrane-proximal tyrosines (9–11).
Microscopy studies have highlighted the clustering of immune re-
ceptors on the plasma membrane (11–15), but the consequences of
clustering remain poorly defined. For example, it is presently unknown
howmembrane localization and the degree of clustering influence the
local substrate concentration experienced by SHP-1. Mathematical
models can predict large local substrate concentrations for certain
tethers (16–18), whichmay even override the catalytic specificity of en-
zymes (19). This may explain the observation that SHP-1 and SHP-2
can regulate the phosphorylation state of the clustered inhibitory re-
ceptors they interact with (11).Solution-based in vitro assays for enzymatic activity have been
instrumental to our understanding of signaling and, particularly, to
SHP-1 (5, 6). These experimentsmeasure the reactionproduct over time
after mixing the enzyme and substrate in solution, and model fitting
produces an estimate for the overall catalytic rate k∗cat (= kcat/Km, where
Km is theMichaelis constant) (20). Applying this assay to SHP-1 (Fig. 1,
A and B) makes it clear that this single number coarse-grains the reac-
tion mechanism when proteins have multiple domains that interact
with substrates, and moreover, the tether does not influence these reac-
tion rates.
Surface plasmon resonance (SPR), as implemented in commercial
instruments such as Biacore (GE Healthcare), is a widely used bio-
physical assay for molecular interactions (21). In a typical experiment,
one binding partner is immobilized to a surface, whereas the other is
injected over it. The instrument reports a highly accurate measure of
themass ofmaterial bound at the surface, expressed as resonance units
(RU), as a function of time. The resulting data are fit to mathematical
models to determine the association rate (kon) and dissociation rate
(koff). High sensitivity and accuracy and the availability of many sur-
face chemistries resulted in the method gaining considerable popular-
ity not only for biomedical research but also for medical diagnostics,
food safety and security, and environmental monitoring (21). Despite
these advances, the method remains largely a tool for the study of mo-
lecular binding.
Here, we retool SPR for the study of tethered enzymatic reactions
applied to SHP-1. Injection of SHP-1 over a surface immobilized with
phosphorylated peptides produced a noncanonical SPR trace as a result
of tethered dephosphorylation reactions of clustered peptides. Using a
mathematical analysis that captures both the spatial and stochastic
elements of tethered reactions, we show that five biophysical and bio-
chemical constants can be independently extracted from a single SPR
trace. We found that binding of either of the SH2 domains to the tether
allosterically activated SHP-1 and that the tether length modulated not
only the reach but also the binding and catalysis.Using these parameters,
we find that tethering increases reaction rates by 900-fold with a tether-
induced local increase in substrate concentration as the dominant con-
tribution, but onlywhen receptors are clusteredwithin 5 nm.Collectively,1 of 14
SC I ENCE ADVANCES | R E S EARCH ART I C L Ethis work highlights tethering as a control parameter for signaling re-
actions and provides a previously unreported SPR-based platform for
the study of tethered signaling, with implications for drug discovery.RESULTS
Tethered enzymatic reactions produce a noncanonical
SPR trace
To create a substrate surface for SHP-1 in SPR, we coated a surface
with peptides containing an ITIM sequence, from the N terminus of
the inhibitory receptor LAIR-1, with a 28-repeat polyethylene glycol
(PEG) spacer (PEG28-ITIM; Table 1).When SHP-1 was injected over
this surface, we observed a complicated curve with an initial binding
phase that was quickly followed by a reduction in binding despite con-
tinuous injection of SHP-1 (Fig. 2A). To convert the arbitrary response
units reported by the SPR instrument to a more meaningful unit, we
normalized this curve to maximum binding, assuming a one-to-one
interaction with peptide (see Materials and Methods). We confirmed
that SHP-1 was dephosphorylating the substrate by injecting an anti-
phosphotyrosine antibody following the injection of SHP-1, which re-
vealed near complete dephosphorylation (Fig. 2B).
The decrease in binding, despite continuous injection of SHP-1, can
be understood by considering the catalytic activity of the enzyme that
over time destroys binding sites for its SH2 domains. When SHP-1 is
first injected over the surface, it begins binding via the SH2 domains
(initial rise within the first 3 s; Fig. 2A). This binding (or tethering) in-
creases the dephosphorylation rate by confining SHP-1 and its phos-
phorylated substrates to a restricted volume, resulting in the rapid
destruction of highly clustered phosphorylated peptides (steep fall be-
tween 3 and 100 s; Fig. 2A). However, the rate of dephosphorylation byGoyette et al., Sci. Adv. 2017;3 : e1601692 24 March 2017tethered SHP-1 decreases over time because the tethered enzyme is un-
able to reach remaining phosphorylated peptides, whose average dis-
tance increases over time. This inefficient tethered dephosphorylation
combined with inefficient solution dephosphorylation leads to a slow
loss in overall binding at later time points (slowly decreasing asymptote
after 100 s; Fig. 2A). Consistent with this interpretation, we observed
negligible bindingbut partial dephosphorylationwhenpointmutations
were introduced to both SH2 domains (fig. S2). These interactions are
summarized in Fig. 2C.
A mathematical model quantifies the tethered enzymatic
SPR assay
The tethered enzymatic SPR assay is heavily influenced by stochastic
fluctuations. This may seem counterintuitive because the instrument re-
ports macroscopic binding averaged over picomoles of protein across a
millimeter-scale surface.However, tethered catalytic reactions are limited
to the number of peptide substrates within reach, which we estimate to
be ~8 initially (assuming [peptide] = 100 mMwith a reach of 25 nm) and
over time to reach 0. Therefore, the SPR trace represents the average of
many realizations of a low copy number stochastic process.
We therefore developed a spatial stochastic simulation to reproduce
the tethered enzymatic SPR assay. The model includes the kinetics of
SHP-1binding tophosphorylatedpeptides by its SH2domains [governed
by the on-rate (kon) and off-rate (koff) constants], the dephosphorylation
of peptides when SHP-1 is bound to the surface [k∗cat ðtetheredÞ], or
when SHP-1 is free in solution [k∗cat ðsolutionÞ] (Fig. 2C). The local con-
centration of peptide experienced by tethered SHP-1 is determined by
the reach parameter L, which is defined as the quadrature average of the
average reach distance of the peptide and the average reach distance of
SHP-1 bound to a peptide. This calculation is based on approximating
the motion of both the free and bound peptides using the worm-like
chain polymer model (seeMaterials andMethods). The stochastic sim-
ulation was used to plot the three molecular species over time and to
provide spatial snapshots of these species at different times (Fig. 3). As
expected, we found that clustered peptides were preferentially destroyed,
leading to a nonrandom distribution of the surviving phosphorylated
peptides.
Stochastic simulations often provide intuition but are not practical
for data fitting because they require long computation times. We there-
fore developed a computationally efficientmodel. Standarddeterministic
ordinary differential equation (ODE) models fail to fit the experimental
data because they do not account for stochastic fluctuations (fig. S3).WeBA
Fig. 1. Solution-based assays coarse-grain reaction mechanisms for the tyrosine phosphatase SHP-1. (A) Schematic of the domain structure of SHP-1 and a
subset of reactions that may occur in solution with peptide substrates. (B) Standard solution–based enzymatic assay showing the production of inorganic phosphate
(product) over time for the indicated concentration of SHP-1 mixed with the PEG12-ITIM substrate (data are representative of two independent experiments). Progress
curves are fit with a mathematical model to provide an estimate for k∗cat (see Materials and Methods).Table 1. Peptides used in study (phosphotyrosines are denoted as Y*).Name Sequence Contour lengthPEG28-ITIM Biotin-(PEG)28-DLQEVTY*IQLDHH 12.1 nmPEG12-ITIM Biotin-(PEG)12-DLQEVTY*IQLDHH 6.5 nmPEG3-ITIM Biotin-(PEG)3-DLQEVTY*IQLDHH 3.3 nmPEG0-ITIM Biotin-GDLQEVTY*IQLDHH 2.7 nm2 of 14
SC I ENCE ADVANCES | R E S EARCH ART I C L Etherefore used the multicenter particle density (MPD) formalism, previ-
ously used to study defects in solid-state physics (22–24), to develop a
hybrid integral MPD partial differential equation (MPDPDE) model
that includes the reactions specified for the stochastic simulation (see
Materials andMethods).We found an agreement between the stochastic
simulation and the computationally efficientMPDPDEmodel (Fig. 3A).
Weused theMPDPDEmodel to examine the dependency of the pre-
dicted SPR trace on the experimental variables (SHP-1 and peptide con-
centrations) and on the five model parameters [kon, koff, k∗catðtetheredÞ,
L, and k∗catðsolutionÞ]. We found that the binding trace shifted in non-
intuitiveways (fig. S4). For example, changing the concentration of pep-
tide, which in standard SPR simply changes the scale of the binding
trace, resulted in a change to the shape of the binding trace because a
different proportion of peptides was dephosphorylated by tethered ver-
sus solution enzyme. This underlines the need for a mathematical anal-
ysis of the data.
We next analyzed the SPR data using the MPDPDE model. We
found an excellent fit of the model to the data (Fig. 2A, red line) and
recovered the five model parameters. We performed Markov chain
Monte Carlo (MCMC) analysis to determine whether a different set
of parameters can produce the same binding trace, but we found that
the five recovered parameters are unique (fig. S5). In summary, the
computationally efficient MPDPDEmodel captures the stochastic fluc-
tuations in tethered reactions and can recover five parameters from a
single SPR trace.Goyette et al., Sci. Adv. 2017;3 : e1601692 24 March 2017Fitted biophysical and biochemical constants are
independent of experimental variables
A key test of a mathematical model is the ability to recover the same
parameter values when different experimental variables are used. This
is particularly important for SPR, wheremass transport and rebinding
can produce parameters that are dependent on the concentration of
surface-immobilized receptors (25, 26). We therefore performed ex-
periments at different SHP-1 concentrations and immobilized peptide
concentrations (Fig. 4, A and B). The fitted parameters did not corre-
late with either experimental variable and, moreover, showed excellent
reproducibility (Fig. 4C). As predicted by themodel, changing the con-
centration of immobilized peptide led to a change in the shape of the
SPR binding trace (Fig. 4B), highlighting the difficulty of interpreting
the data without performing model fitting.
Fitted biophysical and biochemical constants are consistent
with the biology of SHP-1
The recovered parameters (Fig. 4C)werewithin the expected range for
tethered signaling by SHP-1. The affinity of SHP-1 interacting with
the LAIR-1 ITIM (KD = 9.38 mM) is in agreement with that for isolated
SH2 domains of SHP-1 interacting with other ITIMs (27). We ob-
served a 20-fold increase in the tethered over solution catalytic rate
[k∗catðtetheredÞ = 1.18 × 10−2 mM−1 s−1 versus k∗catðsolutionÞ = 6.03 ×
10−4 mM−1 s−1], which is consistent with an allosteric activation of
SHP-1 when bound by SH2 domains (6). We note that the standardA
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Fig. 2. An SPR assay recovers five independent biophysical/biochemical constants characterizing tethered enzymatic reactions by SHP-1. (A) Representative
SPR trace (black dots) for SHP-1 injected over a surface immobilized with 48.5 RU of an ITIM peptide derived from LAIR-1 on a 28-repeat PEG linker (PEG28-ITIM). A fit of the
MPDPDE model (red line) provides estimates for the indicated parameters. Early time data and fit are shown on the right. Unprocessed data are shown in fig. S1. (B) Anti-
phosphotyrosine antibody injected at the end of the experiment shows reduced binding in the experimental flow cell (SHP-1) compared to a buffer-injected flow cell with
equivalent peptide levels (control). (C) Schematic of reactions taking place when SHP-1 is injected over a surface of immobilized phosphorylated peptides. Note that
peptide anchoring is displayed in one dimension for clarity, but because peptides are randomly coupled to a dextran matrix, which extends 100 to 200 nm above the
surface, they are anchored in three dimensions.3 of 14
SC I ENCE ADVANCES | R E S EARCH ART I C L Esolution–based assay recovered an overall catalytic rate that was be-
tween these two rates (kcat = 6.8 × 10
−3 mM−1 s−1; Fig. 1B), consistent
witha combinationof inactive andallosterically active SHP-1mediating
dephosphorylation in solution.
The tethered enzymatic SPR assay also produced an estimate for the
reach parameter (L), which was 23 nm. This number corresponds to a
phosphorylated substrate experiencing a maximum local SHP-1 con-
centration of 45 mM when tethered, compared to, for example, a con-
centration of 1 mMin solution (Fig. 2A) or in the cytoplasm of immune
cells (see Discussion). To further appreciate the effect of surface tether-Goyette et al., Sci. Adv. 2017;3 : e1601692 24 March 2017ing, we used the fitted parameters to calculate the time required to de-
phosphorylate 50% of the peptides with (9.2 s) and without tethering
(19min), revealing that tethering reduced the reaction time by 125-fold
(fig. S7).
The tether length controls the binding, catalysis, and
reach parameters
To further understand the effects of the reach parameter (L), we per-
formed experiments with different tether lengths. To do this, we re-
duced the length of the spacer from 28 to 0 PEG repeats withoutA
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Fig. 3. Mathematical models capture the physics and chemistry in tethered enzymatic SPR. (A) Levels of unphosphorylated peptide, phosphorylated peptide, and
phosphorylated peptide bound to SHP-1 over time determined using the stochastic simulation (solid gray lines) or the MPDPDE model (dashed colored lines). Levels of
SHP-1 bound to phosphorylated peptide are replotted for clarity (right panel). Good agreement is observed between the stochastic simulation and the MPDPDE model
calculation. (B) Snapshots of the spatial distribution of the three molecular species at indicated time points from the stochastic simulation [colors as in (A)]. Initially, the
phosphorylated peptides are randomly distributed on the surface (0 s), but as time progresses, clustered peptides are effectively dephosphorylated by tethered ca-
talysis (50 s), ultimately resulting in phosphorylated peptides too far apart for efficient tethered catalysis (280 s). These two-dimensional spatial distributions are
generated from the stochastic simulation by projecting 20 nm in the third dimension. See Materials and Methods for computational details. Parameters: [SHP-1] =
1 mM, [peptide] = 100 mM, kon = 0.1 mM
−1 s−1, koff = 1 s
−1, k∗cat ðtetheredÞ = 0.01 mM−1 s−1, L = 20 nm, and k∗cat ðsolutionÞ = 0.0005 mM−1 s−1.4 of 14
SC I ENCE ADVANCES | R E S EARCH ART I C L Emodifications to the peptide (Table 1). The model produced excellent
fits to all data (Fig. 5A), and as expected, the reach parameter de-
creased with decreasing tether lengths (Fig. 5B). Although there is a
large difference in the contour length between the longest (PEG28,
12.1 nm) and shortest (PEG0, 2.3 nm) tethers, no marked decrease
in L (23 nm for PEG28 and 17 nm for PEG0) was observed. This
implied that SHP-1 itself contributes significantly to the reach length
when it is tethered. This can be understood bynoting that, although the
contour length of the tethers may be long, the average reach distance is
relatively short due to the small persistence length of flexible PEG (28)
and polypeptides (29). Thus, the rigid domains of SHP-1 may contrib-
ute much more to the reach length than one might intuitively expect.
We note that a decrease in kon and k∗catðtetheredÞwas also observed
(Fig. 5B), which likely reflects steric hindrance at short tether lengths
(PEG3 andPEG0). This formof configurational hindrance is a result of
a smaller fraction of time that short linkers spend sufficiently far from
their anchor point to accommodate SHP-1 binding. Thismechanism is
not expected to change koff, which is consistent with the similar koff
values we find across tethers. This effect is significant and indicates that
SPR experiments to measure binding affinities should use long linkers
to avoid configurational steric hindrance.Goyette et al., Sci. Adv. 2017;3 : e1601692 24 March 2017A different reach but a similar allosteric activation is
induced by each SH2 domain of SHP-1
Given that SHP-1 itselfmay significantly contribute to the reach length,
we hypothesized that binding by the N-terminal SH2 domain would
allow SHP-1 to reach further compared to theC-terminal SH2 domain.
We generated SHP-1 variants with inactivating point mutations to ei-
ther SH2 domain. Mutation of the N-terminal SH2 domain showed
drastically reduced binding, whereas mutation of the C-terminal
SH2 domain showed a weak effect on binding (Fig. 6, A and B), clearly
demonstrating that the N-terminal SH2 domain dominates the inter-
action of wild-type SHP-1 to themembrane-proximal ITIMof LAIR-1.
As expected, a reduction in the reach parameter was observed for
the N-terminal mutant (L = 16.5 nm) compared to the wild-type (L =
23.0 nm) and C-terminal mutant (L = 23.9 nm) because binding via
the C-terminal SH2 reduced the overall reach (Fig. 6B). This difference
is more than twice as large as the spatial extent of the C-terminal SH2
domain (~3 nm, estimated from structure), which reflects the large
effective persistence length of structured domains.
In contrast to previous studies, we found that the N-terminal mu-
tant still exhibited allosteric activation because k∗catðtetheredÞ remained
10-fold larger thank∗catðsolutionÞ. Therefore, binding of either the N- orA
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Fig. 4. Fitted biophysical/biochemical parameters are independent of experimental variables. Representative SPR traces (black dots) and MPDPDE model fits
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time scale artifacts, such as nonspecific binding and/or differential flow cell drift, are discussed in Materials and Methods (Quality control) and fig. S6.5 of 14
SC I ENCE ADVANCES | R E S EARCH ART I C L EC-terminal SH2 domain is sufficient to allosterically activate SHP-1.
We also found that the kon differed by ~10-fold between the N- and
C-terminal SH2 domains, but the koff was nearly identical (Fig. 6B).DISCUSSION
Our understanding of tethered signaling reactions is limited by the lack
of experimental methods. We have described a previously unreported
SPR-based assay for tethered enzymatic reactions that, from a single
experiment, can recover five biophysical and biochemical constants
that quantify tethered signaling for SHP-1 with clustered substrates.
We demonstrate that these constants can be determined with high ac-
curacy, as a result of the high sensitivity of SPR, and we further show
that they are independent of the SHP-1 and substrate concentrations.
We observed that reducing tether lengths below ~12 nm (PEG28)
introduces a steric penalty to binding, implying a lower bound on the
cytoplasmic tails of inhibitory receptors that recruit SHP-1 (Fig. 7A).
A bioinformatic analysis of inhibitory receptors reveals that most re-
ceptors contain ITIMs that are located≥12 nm from the plasmamem-
brane (Fig. 7B). Most activatory receptors contain tyrosines that are
located ≤12 nm from the plasma membrane. This finding raises the
possibility that tethers may have a role in binding specificity by, for
example, sterically preventing binding of signaling enzymes.
Activatory and inhibitory immune receptors are both known to
cluster in the plasma membrane (11–15), but the extent and con-
sequences of clustering remain poorly understood. In the absence of
clustering, a phosphorylation site on the cytoplasmic tails of these re-
ceptors will experience the low ~1-mM concentration of cytoplasmic
SHP-1 [based on 280,000 copies of SHP-1 in cytotoxic T cells (30) with a
radius of 5 mm]. Tethering of SHP-1 to nonclustered immune receptors
at distances >50 nm results in even lower concentrations (for example,Goyette et al., Sci. Adv. 2017;3 : e1601692 24 March 20170.04 mMwhen receptors are 50-nm apart), but when clustered within
5 nm,we can now estimate that this phosphorylated site will experience
an SHP-1 concentration of 45 mM (Fig. 8A). This concentration is ex-
quisitely sensitive to the degree of clustering so that a 10-fold decrease
in receptor clustering (5 to 50 nm) results in a 1125-fold decrease in
concentration (45 to 0.04 mM). These concentrations are calculated
using the formula for s with L = 23 nm for r = 5 and 50 nm (see
Materials and Methods). We note that this is based on a reach of
L = 23 nm, which represents SHP-1 bound to an ITIM on PEG28
dephosphorylating another ITIM on PEG28. We expect the value
of L to decrease and, hence, the local concentration to increase when
SHP-1 dephosphorylates other substrates such as ITAMs on shorter
activatory receptor tails.
The current model for SHP-1 activation is based on an allosteric
conformational change into an “open” high catalytic activity state in-
duced by N-terminal SH2 domain binding (Fig. 8B) (6, 8, 31). In agree-
ment with this model, we have found a 20-fold increase in the catalytic
rate when the SH2 domains are engaged (tethered versus solution cat-
alytic rates; Fig. 4C). The sensitivity of the present assay has revealed
that the C-terminal SH2 domain can also induce the open state, sug-
gesting that the “closed” low catalytic activity state may involve occlu-
sion of the catalytic domain by either SH2domain. The observation that
unbound (solution) SHP-1 exhibits catalytic activity, albeit less effi-
ciently, suggests that it is in equilibrium between closed and open states
in solution. Assuming the open state transition is complete upon SH2
binding and that the activity of the open state is similar when tethered
or when achieved spontaneously when unbound, our results suggest
that SHP-1 spends only 5% of the time in the open active conformation
in solution [that is, k∗catðsolutionÞ ¼ 0:05k∗catðtetheredÞ].
The combined effects induced by SHP-1 tethering on allosteric ac-
tivation (20-fold) and local substrate concentration (45-fold) can beA
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SC I ENCE ADVANCES | R E S EARCH ART I C L Esummarized by calculating the dephosphorylation rate ([SHP-1] × k∗cat).
We find a similar rate when SHP-1 is in solution or tethered but not
clustered (1 mM×0.000603 mM−1 s−1 versus 0.04 mM×0.0118 mM−1 s−1),
but observe a 900-fold increase in the dephosphorylation rate when
tethered and clustered (45 mM × 0.0118 mM−1 s−1).
These calculations and our SPR assay are likely to be valid for reac-
tions within immune receptor clusters. However, SHP-1 and the highly
homologous SHP-2 are involved in diverse reactions within cells that
may include multivalent binding to diffusing receptors. Recent work
using rule-basedmodeling for SHP-2 andphosphatidylinositol 3-kinase
have highlighted the complex set of interactions that are possible with
multivalent reactions across receptor tails and the importance of pa-
rameter values (32, 33). Demonstrations of the enhanced avidity of
SHP-1 and SHP-2 on bivalent substrates have largely been conductedGoyette et al., Sci. Adv. 2017;3 : e1601692 24 March 2017on isolated tandem SH2 domains to eliminate dephosphorylation and
simplify interpretation (34, 35). Here, we found no evidence for bi-
valent reactions, which may reflect the ability of the protein tyrosine
phosphatase (PTP) domain to dephosphorylate tyrosines before the
C-terminal SH2 can bind. Future work with other substrates is needed
to determine whether, and in what context, bivalent reactions can take
place with an active PTP domain. Although the strength of our assay is
the ability to simultaneously parse multiple parameters, mathematical
models based on rule-based frameworks (36, 37) are ultimately needed
to translate the parameters we obtained into the diverse reactions tak-
ing place within cells.
To analyze the SPR data, we used an MPDPDEmathematical anal-
ysis that captures both the spatial and stochastic elements of tethered
signaling. This analysis was previously developed to study annihilation
reactions in solid-state physics (22–24). StandardODEmodels based on
first moment expansions fail to fit the data because, for example, they
are unable to predict the formation of a nonhomogeneous distribution
of phosphorylation produced by tethered reactions. Beyond the SPR as-
say, it is interesting to speculate that these tethered signaling reactions
may lead to the appearance of large-scale phosphorylation patterns in
cells. The appearance of spatial patterns of membrane-localized phos-
phorylation (38) and signaling enzymes (39, 40) (often a proxy for phos-
phorylation) in T cells may be a result of tethered phosphorylation/
dephosphorylation reactions. Future work in a reductionist settingA
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Fig. 6. Binding by either SH2 domain allosterically activates SHP-1, but the
reach parameter is larger for N-SH2 binding. (A) SPR traces (black dots) and
MPDPDE model fits (solid lines) of the N- and C-terminal SH2 domain binding–null
mutants and wild-type SHP-1 injected over PEG28-ITIM. (B) Average fit parameters
for wild-type (WT) SHP-1 (n = 15), N-terminal SH2 (N-SH2) mutant SHP-1 (n = 3), and
C-terminal SH2 (C-SH2) mutant SHP-1 (n = 9) show weak binding and reduced reach
when SHP-1 binds via the C-terminal SH2 domain compared to the N-terminal SH2
domain, but allosteric activation is observed in both cases. Two-way ANOVA with a
Bonferroni multiple comparison correction is used to determine the P values (****P <
0.0001, ***P < 0.001, **P < 0.01, *P < 0.05).Steric effects by short tails
Longer tails Shorter tails
B
A
Fig. 7. Steric penalty to binding and catalysis by short tethers. (A) Shorter
cytoplasmic tails (tethers) result in decreased kon for binding and k∗cat ðtetheredÞ
for catalysis as a result of steric hindrance (indicated by thickness of black arrow).
(B) Histograms of the contour length (number of amino acids × 0.3 nm per amino
acid) to phosphotyrosine residues on inhibitory receptors (ITIM/ITSM;mean length of
21.2 nm, red histogram) and activatory receptors (ITAM/ITTM/YxxM; mean length of
11.3 nm, green histogram) for human receptors. Most inhibitory receptor tails are
longer than PEG28 where steric penalties are lower, whereas most activatory recep-
tor tails are shorter than PEG28 where steric penalties are higher.7 of 14
SC I ENCE ADVANCES | R E S EARCH ART I C L Ecan determinewhether tethered reactions are sufficient to produce these
patterns.
The biophysical assay for tethered enzymatic reactions introduced
here can be used for the study of a large number of tethered signaling
reactions on immune receptors (4). Although we have focused on the
interactions with the tyrosine phosphatase SHP-1, the assay can be
performed with a large number of tyrosine kinases, such as those of
the Src and Syk families, which can both phosphorylate and bind their
substrates. More generally, the method can be used in any situation
where an enzyme can both bind and modify a substrate. Many such
enzymes, SHP-1/SHP-2 included, are attractive therapeutic targets,
and by providing rich mechanistic information, the assay may be par-
ticularly useful to identify drugs that target allosteric mechanisms (41)Goyette et al., Sci. Adv. 2017;3 : e1601692 24 March 2017or tether components. Unlike the catalytic domains of the enzymes
they recruit, tethers such as immune receptor cytoplasmic tails are of-
ten conserved in length but not in sequence, potentially allowing for
more targeted therapeutics. The tethered enzymatic assay is a useful
extension to the already widely used SPR platform for drug discovery
andmechanistic studies (21), but we expect that it can be implemented
in other instruments where binding can be observed over time (for
example, Bio-Layer interferometry).
Tethered signaling reactions are complicated to study because they
depend on multiple factors, such as binding kinetics, catalytic rates, al-
losteric activation, clustering, and tether length/flexibility. The SPR as-
say for tethered enzymatic reactions can parse these effects by providing
five independent biophysical/biochemical parameters governing these
reactions.When applied to SHP-1, the work has revealed that tethering
increases enzymatic rates by 900-fold and that this increase is highly
sensitive to the degree of receptor clustering. This work provides a
new way to quantitatively study tethered signaling processes and has
underlined the tether as a control parameter for signaling.MATERIALS AND METHODS
Plasmids and peptides
A construct expressing murine SHP-1 with an N-terminal 6× His tag
was provided byM. H. Brown.Mutation of the SH2 domains was per-
formed using a quick-change strategy. Themutations introducedwere
R30K and R33E for the N-terminal SH2 domain mutant and R136K
for the C-terminal SH2 domain mutant previously shown to result in
loss of binding (6). All peptides were ordered from PeptideSynthetics
and were certified to be >95% pure. Sequences of peptides used are
shown in Table 1. Peptides sequences were derived from the membrane-
proximal ITIM sequence of mouse LAIR-1 receptor.
Protein production
SHP-1 DNA constructs were transformed into the BL21-CodonPlus
(DE3)-RIPL strain (Agilent Technologies) Escherichia coli and plated
on LB agar with ampicillin (100 mg/ml), and then grown overnight at
37°C. The next day, colonies were innoculated into a 10-ml LB selection
medium [LB medium with ampicillin (100 mg/ml) and chlorampheni-
col (50 mg/ml)], grown overnight at 37°C, and then transferred to 1 liter
of LB selectionmediumwithout chloramphenicol until the optical den-
sity at 600 nmwas 0.6 to 0.8. The cells were then treated with isopropyl-
b-D-thiogalactopyranoside (final concentration, 0.1mM) and harvested
by centrifugation after 20 hours of culture at 25°C.
Bacterial pelletswere resuspended in tris-buffered saline [TBS; 20mM
tris(hydroxymethyl)aminomethane, 150 mMNaCl] with 0.5% Triton
X-100 and protease inhibitors (protease inhibitor cocktail; Sigma),
and then lysed with three 30-s bursts of sonication interspersed with
60-s rest periods on ice. Lysateswere clarified by centriguation at 15,000
relative centrifugal force followed by filtration through a 0.45-mm filter.
Clarified lysates were applied to theNi2+-NTA resin, whichwaswashed
with 10 column volumes of TBS, followed by 10 column volumes of
TBS with 30 mM imidazole, before SHP-1 protein was eluted with
50 mM imidazole in TBS (pH 7.5). Glycerol was added to a final con-
centration of 10% (v/v), and protein was stored in aliquots at −40°C
until the day of experiment.
On the day of the experiment, aliquots of SHP-1 and mutants
were thawed and further separated by size-exclusion chromatogra-
phy and AKTA fast protein liquid chromatography (GE Healthcare
Life Sciences) on a Superdex S75 10/300 GL column (GE HealthcareSolutionNonclusteredClustered
[SHP-1]
clustered = 45 x [SHP-1]solution
45 µM 0.04 µM 1.0 µM
k
cat (tethered) = 20 x kcat (solution)
Open (~5%)
Closed (~95%)
Effect of allostery on catalytic rates
Effect of clustering on concentrations
0.0006 µM–1s–1
0.0118 µM–1s–1
A
B
* *
Fig. 8. Clustering and allosteric activation increase the activity of tethered
SHP-1 by 900-fold. (A) The concentration of SHP-1 experienced by the substrate
when SHP-1 is tethered to clustered receptors (left), tethered to nonclustered recep-
tors (center), and free in the cytoplasm (right). The concentration of SHP-1 increases
45-fold as it recruited from solution to clustered receptors. (B) The catalytic rate (k∗cat)
increases 20-fold when SHP-1 is tethered (bound) to a receptor compared to when it
is in solution. This allosteric activation of SHP-1 upon binding is consistent with a
dynamic transition between closed low-activity and open high-activity states while
in solution. The combination of increased concentration (45-fold) and increased cat-
alytic activity (20-fold) leads to a 900-fold increase in the overall dephosphorylation
rate because SHP-1 is recruited from solution to clustered receptors.8 of 14
SC I ENCE ADVANCES | R E S EARCH ART I C L ELife Sciences) equilibrated with 20 mM Hepes, 150 mM NaCl, 0.05%
Tween 20, and 1 mM dithiothreitol. Concentrations of fractions
containing SHP-1 were measured using the optical density at 280 nm,
using a Nanodrop ND-1000 spectrophotometer (Thermo Scientific).
Surface plasmon resonance
Experiments were performed on a Biacore 3000 instrument (GE
Healthcare Life Sciences). All experiments were performed at 10°C
and with a buffer flow rate of 10 ml/min. The buffer used was Hepes-
buffered saline (HBS-EP; GE Healthcare Life Sciences), which con-
tained 10 mM Hepes (pH 7.4), 150 mM NaCl, 3 mM EDTA, and
0.005% Surfactant P20.
A CM5 sensorchip was coupled with streptavidin to near satura-
tion (typically between 4000 and 7000 RU) using the amine coupling
kit (GE Healthcare Life Sciences) as described previously (42). After
streptavidin was coupled, biotinylated peptides were injected to give
the indicated concentrations in experimental flow cells, and excess
biotin-binding sites were blocked with biotin in HBS-EP. The molar
ratio of peptide to streptavidin was kept below 1:1 to ensure that pep-
tide immobilization was random and not clustered on the tetravalent
streptavidin molecules. Reference flow cells were treated with buffer
and then blocked with biotin; pilot experiments using unphosphoryl-
ated control peptides in reference flow cells were indistinguishable from
buffer-treated reference flow cells when injected with SHP-1. The chip
surface was then conditioned with 5 × 5-min injections of HBS-EP.
SHP-1 protein in HBS-EP with 1 mM dithiothreitol was then injected
over reference and experimental flow cells in series for 5 min at the in-
dicated concentrations. All SPRdatawere converted from the reference-
subtracted data (in resonance units) to fraction bound by dividing the
resonance units by the theoreticalmaximumresonance units expected if
the experimental flow cell was saturated with bound SHP-1.
Determination of peptide concentration
To determine the concentration of peptide in the assays, we first
needed a conversion factor between the resonance units and the mass
of peptide at the chip surface.We determined this conversion factor by
injecting four concentrations of SHP-1 over a control flow cell on a
CM5 chip and plotting the mass of SHP-1 injected against the raw
resonance unit change. We repeated this on seven flow cells across
four sensor chips to get an average slope of 149 ± 15 RU per g/liter
(±SEM). This constant, together with themolecular weight of the pep-
tide, was used to convert between the resonance units of peptides im-
mobilized and themolar concentration at the chip surface. For example,
48.5 RU of PEG28-ITIM (molecular weight, 3221) was immobilized to
obtain [peptide] = 97.1 mM (Fig. 2A).
Quality control
From the MPDPDE model–simulated SPR traces, one would predict
that thek∗catðsolutionÞ (fig. S4, G and H) and L (fig. S4F) are likely to be
very sensitive to small systematic errors in the SPR trace at longer time
scales. Nonspecific binding and baseline drift are two well-known
sources of such systemic errors that can produce artifacts at long time
scales (see fig. S6A for examples). To exclude data affected by these ar-
tifacts, we propose a simple quality control check that greatly improves
the accuracy of estimating L, k∗catðtetheredÞ, and k∗catðsolutionÞ. As a
measure of the signal-to-noise ratio at long time points, we took the
resonance units 20 s after the injection was completed (noise) and
divided it by the resonance units 20 s before the injection finished
(signal). We found that when the signal-to-noise ratio was greaterGoyette et al., Sci. Adv. 2017;3 : e1601692 24 March 2017than 20%, large aberrations in L,k∗catðtetheredÞ, ork∗catðsolutionÞwere
apparent, depending on whether the drift was above or below
baseline (fig. S6B). Data that had evidence of significant artifact were
excluded from the study based on this criterion (red data points in
fig. S6B).
Calculation of local substrate concentration using a
polymer model
A key component of themodels (described below) is the calculation of
the local substrate concentration that a tethered enzyme experiences.
We assume that the motion of an unbound phosphorylated peptide
(stateA) and themotion of SHP-1 bound to a phosphorylated peptide
(state B) can both be approximated by the worm-like chain model,
which is a widely used polymer model. This model provides the prob-
ability of finding the tip of the polymer at position r
PðrÞ ¼ 3
2pl2
 3=2
exp  3r ⋅ r
2l2
 
where l ¼ ffiffiffiffiffiffilclpp , with lc as the contour length and lp as the persistence
length. When applied to the free phosphorylated substrate, this prob-
ability is taken to be the position of the phosphorylated tyrosine
residue with l = LA. When applied to bound SHP-1, this probability
is taken to be the position of the catalytic pocket of the phosphatase
domainwith l= LB. Using these probabilities, we can calculate the con-
centration of the substrate s(r) that a tethered enzyme will experience
when they are anchored a distance of r apart (fig. S8)
sðrÞ ¼ ∫PAðr′ÞPBðr′  rÞd3r′
where the integration is over all space. Without loss of generality, we
let r ¼ rz^
s rð Þ ¼ 3
2pL2A
 3=2 3
2pL2B
 3=2
∫
2p
0 df∫
p
0 dq∫
∞
0 dr′ ðr′Þ2sinðqÞ
 exp 3ðr′Þ
2
2L2A
 
exp  3
2L2B
ðr′Þ2 þ ðrÞ2  2rr′ cosðqÞ 
 
and by using the variable substitution q ¼ ðr′Þ2 þ r2  2rr′ cosðqÞ
and integrating over q, we find
s rð Þ ¼ 2pL
2
B
3r
 
3
2pLALB
 3
∫
∞
0 dr′ r′ exp 
3ðr′Þ2
2L2A
 
 exp  3
2L2B
ðr′ rÞ2
 
 exp  3
2L2B
ðr′ þ rÞ2
  
Evaluating this integral and collecting terms leads to a simple an-
alytical expression for the local substrate concentration
s rð Þ ¼ 3
2pL2
 3=2
exp  3r
2
2L2
 
where L ¼ ffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiL2A þ L2Bp is the reach parameter.
We note that the parameter L2B is the variance of the position of the
tip of the polymer r, which for state B is a compound polymer composed
of a phosphorylated peptide and SHP-1. This position can be decomposed
into r = rA + rS, where rA is the position of the phosphorylated peptide9 of 14
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much longer than its persistence length, the random variables rA and rS
are uncorrelated, and their variances sum linearly, leading toL2B ¼ L2A þ
L2S , where LA is a parameter associated only with the phosphorylated
peptide and LS is a SHP-1–specific parameter. Therefore, the reach
parameter can be expressed as a function of theworm-like chain param-
eters for the phosphorylated peptide and SHP-1, L ¼ ffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffi2L2A þ L2Sp .
Mathematical model reactions
Wedevelopeda stochastic andadeterministicmodel for tethered enzymatic
SPR that are based on the same reactions. In this section, we describe the re-
actions in general before themodels are described in the sections that follow.
Themodels are initialized with phosphorylated substrate distribut-
ed randomly in space (state A). A phosphorylated substrate can be
bound by an enzyme (state B) with first-order kinetics
A
k∗on
⇌
koff
B
where k∗on and koff are in units of s
−1. The bimolecular on-rate (kon, in the
unit mM−1 s−1) is related to the first-order on-rate by k∗on ¼ kon [SHP-1],
where [SHP-1] is the concentration of the injected enzyme (in units of
micromolar). When the enzyme is bound, it can dephosphorylate sub-
strates within reach
Aþ B ⇀msðr;LÞ Bþ C
whereC is the unphosphorylated substrate,s(r) is the local concentration
(in units ofmicromolar, see above), and m is the surface catalytic rate (in
the unitmM−1 s−1).Wenote that m ¼ k∗catðtetheredÞand is used for clarity
in the derivations of the mathematical models below. Last, phosphoryl-
ated substrate canbedephosphorylated by enzymedirectly from solution
A ⇀l C
where l is the solution dephosphorylation rate (in the unit s−1). The so-
lution catalytic rate, k∗catðsolutionÞ, in the unit mM−1 s−1, is related to the
solution dephosphorylation rate by l ¼ k∗catðsolutionÞ [SHP-1].
Note thatA,B, andC represent peptide polymers that are anchored
at a fixed locationwithin the volume of the dextranmatrix.We assume
that the dextran matrix is stiff compared to the peptide polymers so
that interactions between A and B in the matrix are determined pri-
marily by the combined reach of the peptide polymers and the enzyme.
Stochastic simulation
The overall state of the stochastic model can be represented by the
positionsof the substratemolecules andeachmolecule’s current chemical
state (one ofA, B, or C). Because the substrates are immobile, the system
can be modeled by a collection of discrete-state jump Markov processes
with rates (that is, propensities) for reactions as given in the preceding
section. Our stochastic simulation engine generated exact realizations
of these processes using the Gibson-Bruck next-reaction method (43)
variant of the well-known stochastic simulation algorithm (44).
The simulation is initialized with a random distribution of peptide
substrates in a cube. The side length of the cube is determined by the
initial concentration of peptides and the absolute number of peptides,Goyette et al., Sci. Adv. 2017;3 : e1601692 24 March 2017which is a simulation parameter taken to be 500,000. For computation-
al efficiency, we define a maximum support of 4.5 × L so that reactions
between a bound enzyme (B) and a free phosphorylated peptide sub-
strate (A) that are anchored to a distance larger than the maximum
support are ignored. This is reasonable because the concentration of
substrate that a bound enzyme experiences at the maximum support
is s(4.5L) ≈ 10− 14 mM. Increasing the maximum support produced
identical simulations but required longer computational times.
Deterministic (standard) ODE calculations
A standard mean field model based on PDEs for tethered reactions
leads to the following set of coupled equations
∂Aðr;tÞ
∂t
¼  k∗on þ l
 
A r;tð Þ þ koffB r;tð Þ 
m∫s r r′ð ÞA r;tð ÞB r′;tð Þd3r′
∂Bðr;tÞ
∂t
¼ k∗onA r;tð Þ  koffB r;tð Þ
where A and B are functions of time (t) and space (r) with initial
conditions A(r, t = 0) = AT and B(r, t = 0) = 0. We note that, as a
result of spatially homogeneous initial conditions, the solution will
be spatially homogeneous at all times because there are no reactions
that break spatial symmetry and, therefore, A(r, t) = A(t) and B(r, t) =
B(t). Using these identities and rescaling by AT, we arrive at the
following ODE system
∂AðtÞ
∂t
¼  p1 þ p4ð ÞA tð Þ þ p2B tð Þ  p3A tð ÞB tð Þ
∂BðtÞ
∂t
¼ p1A tð Þ  p2B tð Þ
withA(t= 0) = 1 and B(t= 0) = 0, and the four fitting parameters (in the
unit s−1) are related to the biophysical constants as follows: p1 ¼ k∗on ¼
kon [SHP-1], p2 = koff, p4 ¼ l ¼ k∗cat ðsolutionÞ [SHP-1], and
p3 ¼ mAT∫sðr  r′Þd3r′ ¼ k∗cat ðtetheredÞ  ½peptide
The expression of p3 highlights that this standard ODE model is
independent of the reach parameter L because ∫s(r − r′)d3r′ = 1. The
value of B(t) was fit to experimental data using lsqcurvefit in Matlab
(Mathworks) using the four fitting parameters (p1, p2, p3, and p4) but
produced a poor fit (see fig. S3).
Deterministic MPDPDE calculations
As discussed in themain text and shown in the previous section, a stan-
dardODEmodel that does not account for stochastic fluctuations failed
to fit the tethered enzymatic SPR data (fig. S3) and, moreover, did not
agree with the stochastic simulations. The low copy number of sub-
strates within reach of tethered enzymes means that stochastic effects
are prevalent. To capture these effects, we used theMPD formalismpre-
viously used in the study of solid state physics (22, 23).
We define rm;m′ as the MPD
rm;m′ ¼ 〈∏
m
i¼1
nAðri;tÞ∏
m′
j¼1
nBðr′j;tÞ〉10 of 14
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for the first five MPDs are
r1;0 ¼ 〈nAðr1;tÞ〉 ≡ nAðtÞ
r0;1 ¼ 〈nBðr′1;tÞ〉 ≡ nBðtÞ
r2;0 ¼ 〈nAðr1;tÞnAðr2;tÞ〉 ≡ n2AðtÞXAðt; r1  r2Þ
r0;2 ¼ 〈nBðr′1;tÞnBðr′2;tÞ〉 ≡ n2BðtÞXBðt; r′1  r′2Þ
r1;1 ¼ 〈nAðr1;tÞnBðr′1;tÞ〉 ≡ nAðtÞnBðtÞYðt; r1  r′1Þ
where we have defined nA and nB as the concentration of A and B, re-
spectively, andXA, XB, and Y are the autocorrelation function forA, the
autocorrelation function for B, and the pair correlation function be-
tweenA and B, respectively. Note that XA,XB, and Y are dimensionless.
The general set of PDEs governing the dynamics of theMPDs based on
the reactions outlined above are
∂rm;m′=∂t ¼  ∑
m
i¼1
∑
m′
j¼1
msðri  r′j Þrm;m′
∑
m
i¼1
∫msðri  r′m′þ1Þrm;m′þ1d3r′m′þ1 þ k∗onðm′ rmþ1;m′1Þ þ
koff ðmrm1;m′þ1Þ  ðlþ k∗onÞðmrm;m′Þ  koff ðm′ rm;m′Þ
where the parameters have been previously defined. The explicit expres-
sions for the first five MPDPDEs are
∂r1;0=∂t ¼ ðk∗on þ lÞr1;0 þ koffr0;1  ∫msðr1  r′1Þr1;1d3r′1
∂r0;1=∂t ¼ k∗onr1;0  koffr0;1
∂r1;1=∂t¼ðk∗onþkoff þlÞr1;1þk∗onr2;0þkoffr0;2msðr1 r1Þr1;1
∫msðr1  r′2Þr1;2d3r′2
∂r2;0=∂t ¼ 2koffr1;1  2ðk∗on þ lÞr2;0  ∫msðr1  r′1Þr2;1d3r′1 
∫msðr2  r′1Þr2;1d3r′1
∂r0;2=∂t ¼ 2k∗onr1;1  2koffr0;2
To uncouple the infinite hierarchy of these PDEs, we use Kirkwood’s
approximation
〈n r1ð Þn r2ð Þn r3ð Þ〉 ≈ 〈nðr1Þnðr2Þi〈nðr1Þnðr3Þ〉〈nðr2Þnðr3Þ〉nðr1Þh i〈nðr2Þ〉 nðr3Þ〉h
which in our case leads to
r1;2 ≈
〈nAðr1ÞnBðr 01 Þi〈nAðr1ÞnBðr′2Þ〉〈nBðr′1ÞnBðr′2Þ〉
〈nAðr1Þ〉〈nBðr′1Þ〉〈nBðr′2Þ〉
¼ nAn2BXBðr′1 r′2ÞYðr1  r′1ÞYðr1  r′2ÞGoyette et al., Sci. Adv. 2017;3 : e1601692 24 March 2017and
r2;1 ≈
〈nAðr1ÞnAðr2Þi〈nAðr1ÞnBðr′1Þ〉〈nAðr2ÞnBðr′1Þ〉
〈nAðr1Þi〈nAðr2Þ〉〈nBðr′1Þ〉
¼ n2AnBXAðr1  r2ÞYðr1  r′1ÞYðr2  r′1Þ
We next express the derivatives of the first five MPDs in terms of their
definitions (nA, nB, XA, XB, and Y) to obtain
∂r1;0=∂t ¼ ∂nA=∂t
∂r0;1=∂t ¼ ∂nB=∂t
∂r2;0=∂t ¼ 2nAXA∂nA=∂t þ n2A∂XA=∂t
∂r0;2=∂t ¼ 2nBXB∂nB=∂t þ n2B∂XB=∂t
∂r1;1=∂t ¼ nBY∂nA=∂t þ nAY∂nB=∂t þ nAnB∂Y=∂t
Using these derivatives together with the simplified expressions for
r1,2 and r2,1 obtained using Kirkwood’s approximation, we can simplify
the first five MPDPDEs as follows
∂nA=∂t ¼ ðk∗on þ lÞnA þ koffnB  nAnB∫msðr′ÞYðr′Þd3r′
∂nB=∂t ¼ k∗onnA  koffnB
∂Y=∂t ¼ k
∗
onnA
nB
XA  Yð Þ þ koffnBnA XB  Yð Þ  ms rð ÞY
nBY∫msðr′ÞYðr′Þ

XBðr r′Þ  1

d3r′
∂XA=∂t ¼ 2koffnBnA Y  XAð Þ 
nBXA∫msðr′ÞYðr′Þ

Yðr′ rÞ þ Yðr′þ rÞ  2

d3r′
∂XB=∂t ¼ 2k
∗
onnA
nB
Y  XBð Þ
The initial conditions for this integral MPDPDE system are nA(t = 0) =
[peptide],nB(t=0) = 0,XA(t=0, r) = 1,XB(t=0, r) = 1, andY(t=0, r) = 1.
A numerical solution of this integral MPDPDE system can be
obtained by noting that there are two distinct types of integrals.
The first integral, appearing in the equation for nA, is evaluated
by defining r′j j ¼ r′ to obtain
∫Gðr′Þd3r′ ¼ ∫∞0 dr′ ∫
2p
0 df′ ∫
p
0 dq′ ½ðr′Þ2sinðq′ÞGðr′Þ
¼ 4p∫∞0 dr′½ðr′Þ2Gðr′Þ
The second integral, appearing in the equations for Y and XA, is
evaluated by defining q ¼ r  r′j j ¼
ffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffi
r2 þ ðr′Þ2  2rr′ cosðq′Þ ,
where, without loss of generality, it is assumed that r = r^z, so that
∫Gðr r′Þd3r′ ¼ ∫∞0 dr′∫
2p
0 df∫
p
0 dq′½ðr′Þ2sinðq′ÞGðjr r′jÞ
¼ 2p
r
∫
∞
0 dr
0∫
jrþr′j
jrr′j dq qr
0GðqÞ½ 11 of 14
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ing nA and nB by [peptide] and r by L, we arrive at the following non-
dimensional MPDPDE system
∂nA=∂t ¼  p1 þ p5
 
nA þ p2nB 
4pð3=2pÞ3=2p3nAnB∫
∞
0 dr
0 ðr′Þ2e3ðr′Þ
2
2 Y r′ð Þ
	 

∂nB=∂t ¼ p1nA  p2nB
∂Y=∂t ¼ p1nA
nB
XA  Yð Þ þ p2nBnA XB  Yð Þ 
3
2p
 3=2
p4e
3r22 Y 
2p
3
2p
 3=2
p3
nBY
r
∫
∞
0 dr
0∫
jrþr′j
jrr′j dq qr′ e
3ðr′Þ22 Y r′ð Þ XBðqÞ  1ð Þ
	 
 
∂XA=∂t ¼ 2p2nBnA Y  XAð Þ 
4p
3
2p
 3=2
p3
nBXA
r
∫
∞
0 dr′ ∫
jrþr′j
jrr′j dq qr′ e
3ðr′Þ22 Y r′ð Þ YðqÞ  1ð Þ
	 
 
∂XB=∂t ¼ 2p1nAnB ðY  XBÞ
with initial conditions nA(t = 0) = 1, nB(t = 0) = 0, XA(t = 0, r) = 1,
XB(t = 0, r) = 1, and Y(t = 0, r) = 1.
The five fitting parameters (p1, p2, p3, p4, and p5) are related to the
five biophysical/biochemical constants as follows: p1 = kon [SHP-1], p2 =
koff, p3 ¼ k∗catðtetheredÞ [peptide], p4 ¼ k∗catðtetheredÞ=L3, and p5 ¼
k∗catðsolutionÞ[SHP-1].
The two numerical parameters are the spatial discretization (DR)
and the integration upper bound (Rmax). We found that DR = 0.05
and Rmax = 4.5 (maximum support at which the infinite integrals were
truncated) introduced errors that were substantially smaller than exper-
imental noise while maintaining the computational efficiency required
for data fitting.
The MPDPDE model was fit to the experimental data using
lsqcurvefit in Matlab (Mathworks). Specifically, the value of nB from
the MPDPDE model was fit to the experimental SPR data that were
normalized to maximum binding. Each fit was repeated multiple
times with different initial guesses for the five fitting parameters to
make certain that the best fit was achieved (global convergence). Fur-
thermore, we performedMCMC, using a previously publishedMatlab
toolbox (45), on a subset of the experimental data to show that the five
fitted parameters can be determined independently from a single SPR
time course (see fig. S5 for MCMC analysis of the fit in Fig. 2A). The
numerical code for solving theMPDPDEmodel inMatlab is provided
(Supplementary Online Material). All experimental data in the pres-
ent manuscript is provided as an Excel spreadsheet (Supplementary
Online Material).
Solution phosphatase assay
Purified SHP-1wasmixedwithPEG12-ITIMpeptide at 10mM, in10mM
Hepes (pH7.4), 150mMNaCl, 3mMEDTA, 0.005%Surfactant P20, and
1 mM dithiothreitol (Sigma). Temperature was regulated to 10°C with a
thermocycler heat block, and the production of inorganic phosphate
wasmeasured at the indicated time points using BIOMOLGreen (Enzo
Life Sciences).Goyette et al., Sci. Adv. 2017;3 : e1601692 24 March 2017The resulting progress curves (Fig. 1B) were fit using a standard
mathematical model (20) based on the following reaction scheme
F þ S∗⇌kon
koff
C⇀
kcat F þ S
where F is the phosphatase, S* is the phosphorylated peptide sub-
strate, S is the unphosphorylated peptide product, and C is the
intermediate enzyme-substrate complex. This reaction scheme
corresponds to the following coupled ODEs
∂F=∂t ¼ konFS∗ þ ðkoff þ kcatÞC
∂S∗=∂t ¼ konFS∗ þ koffC
∂C=∂t ¼ konFS∗  ðkoff þ kcatÞC
∂S=∂t ¼ kcatC
with the following conservation equations for the enzyme and substrate,
FT ¼ E þ C
ST ¼ S∗ þ C þ S
where FT is the initial SHP-1 concentration and ST is the initial con-
centration of phosphorylated substrate. A common assumption for
in vitro solution-based enzyme assays is that the enzyme-substrate
complex (C) changes on a slower time scale compared to the time scale
of product formation (that is, ∂C/∂t ≈ 0). Using this quasi–steady-
state approximation, which is valid when E≪ S +Km (46, 47), we find
C = FTS
∗/(Km + S
∗). Using this result, together with the conservation
of substrate, we arrive at a simple ODE for the production of un-
phosphorylated peptide
∂S
∂t
¼ kcatFTðST  SÞ
Km þ ðST  SÞ
where kcat is the catalytic rate (in the unit s
−1) and Km is the Michaelis-
Menten constant (in micromolar). The initial condition is S(t = 0) = 0.
This ODEwas solved using ode45 and fit to experimental data using
the function lsqcurvefit inMatlab (Mathworks).We found that a simul-
taneous fit of the model to all the data was sufficient to uniquely deter-
mine the three model parameters (kcat, Km, and ST).
SUPPLEMENTARY MATERIALS
Supplementary material for this article is available at http://advances.sciencemag.org/cgi/
content/full/3/3/e1601692/DC1
fig. S1. Unprocessed SPR traces for the data in Fig. 2A showing the binding trace for the
experimental flow cell (black) and the control flow cell (red).
fig. S2. Point mutations to both SH2 domains of SHP-1 result in minimal binding but
appreciable dephosphorylation.
fig. S3. Comparison of the standard and MPDPDE model fits.
fig. S4. Theoretical SPR traces generated by the MPDPDE model.
fig. S5. MCMC analysis of the experimental data in Fig. 2A highlights that all five parameters
can be determined independently of each other.
fig. S6. Quality control of experimental data.
fig. S7. Surface tethering markedly increases the rate of dephosphorylation.
fig. S8. Calculation of local concentration, s(r), based on two polymers a distance of r apart that
can be approximated by worm-like chains with parameter LA for the free phosphorylated
peptide and LB for the SHP-1–bound phosphorylated peptide.
Supplementary code
Supplementary data (Microsoft Excel format)12 of 14
SC I ENCE ADVANCES | R E S EARCH ART I C L EREFERENCES AND NOTES
1. C. R. Weston, R. J. Davis, Signal transduction: Signaling specificity—A complex affair.
Science 292, 2439–2440 (2001).
2. A. S. Shaw, E. L. Filbert, Scaffold proteins and immune-cell signalling. Nat. Rev. Immunol. 9,
47–56 (2009).
3. M. F. Garcia-Parajo, A. Cambi, J. A. Torreno-Pina, N. Thompson, K. Jacobson,
Nanoclustering as a dominant feature of plasma membrane organization. J. Cell Sci. 127,
4995–5005 (2014).
4. O. Dushek, J. Goyette, P. A. van der Merwe, Non-catalytic tyrosine-phosphorylated
receptors. Immunol. Rev. 250, 258–276 (2012).
5. D. Pei, U. Lorenz, U. Klingmuller, B. G. Neel, C. T. Walsh, Intramolecular regulation of
protein tyrosine phosphatase SH-PTP1: A new function for Src homology 2 domains.
Biochemistry 33, 15483–15493 (1994).
6. D. Pei, J. Wang, C. T. Walsh, Differential functions of the two Src homology 2
domains in protein tyrosine phosphatase SH-PTP1. Proc. Natl. Acad. Sci. U.S.A. 93,
1141–1145 (1996).
7. U. Lorenz, SHP-1 and SHP-2 in T cells: Two phosphatases functioning at many levels.
Immunol. Rev. 228, 342–359 (2009).
8. J. Yang, L. Liu, D. He, X. Song, X. Liang, Z. J. Zhao, G. W. Zhou, Crystal structure of human
protein-tyrosine phosphatase SHP-1. J. Biol. Chem. 278, 6516–6520 (2003).
9. J. M. Chemnitz, R. V. Parry, K. E. Nichols, C. H. June, J. L. Riley, SHP-1 and SHP-2
associate with immunoreceptor tyrosine-based switch motif of programmed death
1 upon primary human T cell stimulation, but only receptor ligation prevents
T cell activation. J. Immunol. 173, 945–954 (2004).
10. K.-A. Sheppard, L. J. Fitz, J. M. Lee, C. Benander, J. A. George, J. Wooters, Y. Qiu, J. M. Jussif,
L. L. Carter, C. R. Wood, D. Chaudhary, PD-1 inhibits T-cell receptor induced
phosphorylation of the ZAP70/CD3z signalosome and downstream signaling to PKCq.
FEBS Lett. 574, 37–41 (2004).
11. T. Yokosuka, M. Takamatsu, W. Kobayashi-Imanishi, A. Hashimoto-Tane, M. Azuma,
T. Saito, Programmed cell death 1 forms negative costimulatory microclusters that
directly inhibit T cell receptor signaling by recruiting phosphatase SHP2. J. Exp. Med. 209,
1201–1217 (2012).
12. R. Varma, G. Campi, T. Yokosuka, T. Saito, M. L. Dustin, T cell receptor-proximal signals are
sustained in peripheral microclusters and terminated in the central supramolecular
activation cluster. Immunity 25, 117–127 (2006).
13. T. Yokosuka, W. Kobayashi, K. Sakata-Sogawa, M. Takamatsu, A. Hashimoto-Tane,
M. L. Dustin, M. Tokunaga, T. Saito, Spatiotemporal regulation of T cell costimulation by
TCR-CD28 microclusters and protein kinase C q translocation. Immunity 29, 589–601
(2008).
14. A. Oszmiana, D. J. Williamson, S.-P. Cordoba, D. J. Morgan, P. R. Kennedy, K. Stacey,
D. M. Davis, The size of activating and inhibitory killer Ig-like receptor nanoclusters is
controlled by the transmembrane sequence and affects signaling article. Cell Rep. 15,
1957–1972 (2016).
15. S. V. Pageon, T. Tabarin, Y. Yamamoto, Y. Ma, P. R. Nicovich, J. S. Bridgeman,
A. Cohnen, C. Benzing, Y. Gao, M. D. Crowther, K. Tungatt, G. Dolton, A. K. Sewell,
D. A. Price, O. Acuto, R. G. Parton, J. J. Gooding, J. Rossy, J. Rossjohn, K. Gaus,
Functional role of T-cell receptor nanoclusters in signal initiation and
antigen discrimination. Proc. Natl. Acad. Sci. U.S.A. 113, E5454–E5463 (2016).
16. B. Windisch, D. Bray, T. Duke, Balls and chains—A mesoscopic approach to tethered
protein domains. Biophys. J. 91, 2383–2392 (2006).
17. V. M. Krishnamurthy, V. Semetey, P. J. Bracher, N. Shen, G. M. Whitesides, Dependence
of effective molarity on linker length for an intramolecular protein-ligand system.
J. Am. Chem. Soc. 129, 1312–1320 (2007).
18. D. Van Valen, M. Haataja, R. Phillips, Biochemistry on a leash: The roles of tether length
and geometry in signal integration proteins. Biophys. J. 96, 1275–1292 (2009).
19. A. P. Won, J. E. Garbarino, W. A. Lim, Recruitment interactions can override catalytic
interactions in determining the functional identity of a protein kinase. Proc. Natl. Acad.
Sci. U.S.A. 108, 9809–9814 (2011).
20. R. G. Duggleby, Analysis of enzyme progress curves by nonlinear regression. Methods
Enzymol. 249, 61–90 (1995).
21. J. Homola, Surface plasmon resonance sensors for detection of chemical and biological
species. Chem. Rev. 108, 462–493 (2008).
22. E. Kotomin, V. Kuzovkov, Some problems of recombination kinetics. Chem. Phys. 76,
479–487 (1983).
23. H. Schnörer, V. Kuzovkov, A. Blumen, Bimolecular annihilation reactions with immobile
reactants. J. Chem. Phys. 92, 2310–2316 (1990).
24. V. Kuzovkov, E. Kotomin, Kinetics of bimolecular reactions in condensed media:
Critical phenomena and microscopic self-organisation. Rep. Prog. Phys. 51, 1479–1523
(1988).
25. D. G. Myszka, X. He, M. Dembo, T. A. Morton, B. Goldstein, Extending the range
of rate constants available from BIACORE: Interpreting mass transport-influenced binding
data. Biophys. J. 75, 583–594 (1998).Goyette et al., Sci. Adv. 2017;3 : e1601692 24 March 201726. B. Goldstein, D. Coombs, X. He, A. R. Pineda, C. Wofsy, The influence of transport
on the kinetics of binding to surface receptors: Application to cells and BIAcore.
J. Mol. Recognit. 12, 293–299 (1999).
27. M. C. Sweeney, A.-S. Wavreille, J. Park, J. P. Butchar, S. Tridandapani, D. Pei, Decoding
protein-protein interactions through combinatorial chemistry: Sequence specificity of
SHP-1, SHP-2, and SHIP SH2 domains. Biochemistry 44, 14932–14947 (2005).
28. H. Lee, R. M. Venable, A. D. Mackerell Jr., R. W. Pastor, Molecular dynamics studies of
polyethylene oxide and polyethylene glycol: Hydrodynamic radius and shape
anisotropy. Biophys. J. 95, 1590–1599 (2008).
29. H.-X. Zhou, Loops in proteins can be modeled as worm-like chains. J. Phys. Chem. B 105,
6763–6766 (2001).
30. J. L. Hukelmann, K. E. Anderson, L. V. Sinclair, K. M. Grzes, A. B. Murillo,
P. T. Hawkins, L. R. Stephens, A. I. Lamond, D. A. Cantrell, The cytotoxic T cell
proteome and its shaping by the kinase mTOR. Nat. Immunol. 17, 104–112
(2016).
31. W. Wang, L. Liu, X. Song, Y. Mo, C. Komma, H. D. Bellamy, Z. J. Zhao, G. W. Zhou,
Crystal structure of human protein tyrosine phosphatase SHP-1 in the open
conformation. J. Cell. Biochem. 112, 2062–2071 (2011).
32. D. Barua, J. R. Faeder, J. M. Haugh, Structure-based kinetic models of modular signaling
protein function: Focus on Shp2. Biophys. J. 92, 2290–2300 (2007).
33. D. Barua, J. R. Faeder, J. M. Haugh, Computational models of tandem Src homology
2 domain interactions and application to phosphoinositide 3-kinase. J. Biol. Chem. 283,
7338–7345 (2008).
34. E. A. Ottinger, M. C. Botfield, S. E. Shoelson, Tandem SH2 domains confer high specificity
in tyrosine kinase signaling. J. Biol. Chem. 273, 729–735 (1998).
35. L. Nagase, T. Hayashi, T. Senda, M. Hatakeyama, Dramatic increase in SHP2 binding
activity of Helicobacter pylori Western CagA by EPIYA-C duplication: Its implications in
gastric carcinogenesis. Sci. Rep. 5, 15749 (2015).
36. L. A. Chylek, L. A. Harris, J. R. Faeder, W. S. Hlavacek, Modeling for (physical) biologists: An
introduction to the rule-based approach. Phys. Biol. 12, 045007 (2015).
37. L. A. Harris, J. S. Hogg, J.-J. Tapia, J. A. P. Sekar, S. Gupta, I. Korsunsky, A. Arora, D. Barua,
R. P. Sheehan, J. R. Faeder, BioNetGen 2.2: Advances in rule-based modeling.
Bioinformatics 32, 3366–3368 (2016).
38. Y. Neve-Oz, Y. Razvag, J. Sajman, E. Sherman, Mechanisms of localized activation
of the T cell antigen receptor inside clusters. Biochim. Biophys. Acta 1853, 810–821
(2015).
39. J. Rossy, D. M. Owen, D. J. Williamson, Z. Yang, K. Gaus, Conformational states
of the kinase Lck regulate clustering in early T cell signaling. Nat. Immunol. 14, 82–89
(2013).
40. E. Sherman, V. A. Barr, R. K. Merrill, C. K. Regan, C. L. Sommers, L. E. Samelson, Hierarchical
nanostructure and synergy of multimolecular signalling complexes. Nat. Commun. 7,
12161 (2016).
41. Y.-N. P. Chen, M. J. LaMarche, H. M. Chan, P. Fekkes, J. Garcia-Fortanet, M. G. Acker,
B. Antonakos, C. H.-T. Chen, Z. Chen, V. G. Cooke, J. R. Dobson, Z. Deng, F. Fei, B. Firestone,
M. Fodor, C. Fridrich, H. Gao, D. Grunenfelder, H.-X. Hao, J. Jacob, S. Ho, K. Hsiao,
Z. B. Kang, R. Karki, M. Kato, J. Larrow, L. R. La Bonte, F. Lenoir, G. Liu, S. Liu,
D. Majumdar, M. J. Meyer, M. Palermo, L. Perez, M. Pu, E. Price, C. Quinn, S. Shakya,
M. D. Shultz, J. Slisz, K. Venkatesan, P. Wang, M. Warmuth, S. Williams, G. Yang,
J. Yuan, J.-H. Zhang, P. Zhu, T. Ramsey, N. J. Keen, W. R. Sellers, T. Stams, P. D. Fortin,
Allosteric inhibition of SHP2 phosphatase inhibits cancers driven by receptor tyrosine
kinases. Nature 535, 148–152 (2016).
42. R. Karlsson, A. Michaelsson, L. Mattsson, Kinetic analysis of monoclonal antibody-antigen
interactions with a new biosensor based analytical system. J. Immunol. Methods 145,
229–240 (1991).
43. M. A. Gibson, J. Bruck, Efficient exact stochastic simulation of chemical systems with
many species and many channels. J. Phys. Chem. A 104, 1876–1889 (2000).
44. D. T. Gillespie, Exact stochastic simulation of coupled chemical reactions. J. Phys. Chem.
81, 2340–2361 (1977).
45. H. Haario, M. Laine, A. Mira, E. Saksman, DRAM: Efficient adaptive MCMC. Stat. Comput.
16, 339–354 (2006).
46. L. A. Segel, M. Slemrod, The quasi-steady-state assumption: A case study in perturbation.
SIAM Rev. 31, 446–477 (1989).
47. A. Ciliberto, F. Capuani, J. J. Tyson, Modeling networks of coupled enzymatic reactions
using the total quasi-steady state approximation. PLOS Comput. Biol. 3, e45 (2007).
Acknowledgments: We are grateful to P. A. van der Merwe, D. Vaux, M. H. Brown,
and S. J. Davis for help with protein production, SPR, and/or feedback on the manuscript.
We thank N. Haley, J. Hadida, P. K. Maini, and V. Kuzovkov for feedback on the
mathematical model. Funding: This work is funded by a Sir Henry Dale Fellowship
(to O.D.) jointly funded by the Wellcome Trust and the Royal Society (grant 098363). J.G.
was supported by an Oxford Nuffield Medical Fellowship. S.A.I. was supported by the13 of 14
SC I ENCE ADVANCES | R E S EARCH ART I C L ENational Science Foundation (award DMS-1255408). This work was partially supported
by a grant from the Simons Foundation (to S.A.I.). This work benefited from the Isaac Newton
Institute of Mathematical Sciences (Cambridge, U.K.) programme on Stochastic Dynamical
Systems in Biology. Author contributions: J.G. and O.D. designed the research. J.G.,
N.C.-G., and M.B. performed the experiments. S.A.I. and J.A. developed the stochastic
simulation. C.S.S. and O.D. developed the deterministic model and fitted data. J.G., M.B.,
J.A., and O.D. analyzed the data. J.G. and O.D. wrote the manuscript. All authors
read and commented on the manuscript. Competing interests: The authors declare
that they have no competing interests. Data and materials availability: O.D. and
J.G. has a patent application related to the described work (U.K. Intellectual Property
Office, application 1608058.2). All data needed to evaluate the conclusions in the paperGoyette et al., Sci. Adv. 2017;3 : e1601692 24 March 2017are present in the paper and/or the Supplementary Materials. Additional data related
to this paper may be requested from the authors.
Submitted 21 July 2016
Accepted 9 February 2017
Published 24 March 2017
10.1126/sciadv.1601692
Citation: J. Goyette, C. S. Salas, N. Coker-Gordon, M. Bridge, S. A. Isaacson, J. Allard, O. Dushek,
Biophysical assay for tethered signaling reactions reveals tether-controlled activity for the
phosphatase SHP-1. Sci. Adv. 3, e1601692 (2017).14 of 14
